The p53 protein does not facilitate adenovirus type 5 replication in normal human cells

Journal of Virology

Volumn 87, Issue 10, 2013, Pages 6044-6046

  Chahal, Jasdave S ^a,b   Flint, S J ^a  

^a PRINCETON UNIVERSITY   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADENOVIRUS 5; ARTICLE; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; LIFE CYCLE STAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RNA INTERFERENCE; VIRUS CELL INTERACTION; VIRUS PARTICLE; VIRUS REPLICATION;

ADENOVIRUSES, HUMAN; CELLS, CULTURED; EPITHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; HOST-PATHOGEN INTERACTIONS; HUMANS; RNA INTERFERENCE; TUMOR SUPPRESSOR PROTEIN P53; VIRUS REPLICATION;

EID: 84877330076     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00129-13     Document Type: Article

References (28)

1. Debbas M, White E. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:546 -554.
2. Lowe SW, Ruley HE. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7:535-545.
3. Grand RJ, Grant ML, Gallimore PH. 1994. Enhanced expression of p53 in human cells infected with mutant adenoviruses. Virology 203:229 -240.
4. Mymryk JS, Shire K, Bayley ST. 1994. Induction of apoptosis by adenovirus type 5 E1A in rat cells requires a proliferation block. Oncogene 9:1187-1193.
5. Nakajima T, Morita K, Tsunoda H, Imajoh-Ohmi S, Tanaka H, Yasuda H, Oda K. 1998. Stabilization of p53 by adenovirus E1A occurs through its amino-terminal region by modification of the ubiquitin-proteasome pathway. J. Biol. Chem. 273:20036 -20045.
6. Querido E, Marcellus RC, Lai A, Charbonneau R, Teodoro JG, Ketner G, Branton PE. 1997. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J. Virol. 71:3788 -3798.
7. Steegenga WT, Riteco N, Jochemsen AG, Fallaux FJ, Bos JL. 1998. The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells. Oncogene 16:349 -357.
8. Querido E, Morrison MR, Chu-Pham-Dang H, Thirlwell SW, Boivin D, Branton PE. 2001. Identification of three functions of the adenovirus E4orf6 protein that mediate p53 degradation by the E4orf6-E1B55K complex. J. Virol. 75:699 -709.
9. Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S, White E. 1992. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. U. S. A. 89:7742-7746.
10. White E. 2006. Mechanisms of apoptosis regulation by viral oncogenes in infection and tumorigenesis. Cell Death Differ. 13:1371-1377.
11. Soria C, Estermann FE, Espantman KC, O'Shea CC. 2010. Heterochromatin silencing of p53 target genes by a small viral protein. Nature 466: 1076-1081.
12. Ridgway PJ, Hall AR, Myers CJ, Braithwaite AW. 1997. p53/E1b58kDa complex regulates adenovirus replication. Virology 237:404-413.
13. Hall AR, Dix BR, O'Carroll SJ, Braithwaite AW. 1998. p53-dependent cell death/apoptosis is required for a productive adenovirus infection. Nat. Med. 4:1068 -1072.
14. Dix BR, O'Carroll SJ, Myers CJ, Edwards SJ, Braithwaite AW. 2000. Efficient induction of cell death by adenoviruses requires binding of E1B55k and p53. Cancer Res. 60:2666 -2672.
15. Royds JA, Hibma M, Dix BR, Hananeia L, Russell IA, Wiles A, Wynford- Thomas D, Braithwaite AW. 2006. p53 promotes adenoviral replication and increases late viral gene expression. Oncogene 25:1509 -1520.
16. Harada JN, Berk AJ. 1999. p53-independent and -dependent requirements for E1B-55K in adenovirus type 5 replication. J. Virol. 73:5333- 5344.
17. Gerstung M, Eriksson N, Lin J, Vogelstein B, Beerenwinkel N. 2011. The temporal order of genetic and pathway alterations in tumorigenesis. PLoS One 6:e27136.
18. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. 1998. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72:8463- 8471.
19. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, Weinberg RA, Novina CD. 2003. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9:493-501.
20. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
21. Tiscornia G, Singer O, Verma IM. 2008. Design and cloning of an shRNA into a lentiviral silencing vector: version B. CSH Protoc. 2008: pdb.prot5010.
22. Wold WSM, Horwitz MS. 2007. Adenoviruses, p 2395-2436. In Knipe DM, Howley PM (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
23. Chahal JS, Qi J, Flint SJ. 2012. The human adenovirus type 5 E1B 55 kDa protein obstructs inhibition of viral replication by type I interferon in normal human cells. PLoS Pathog. 8:e1002853
24. Kato SE, Huang W, Flint SJ. 2011. Role of the RNA recognition motif of the E1B 55kDa protein in the adenovirus type 5 infectious cycle. Virology 417:9 -17.
25. Williams JF. 1970. Enhancement of adenovirus plaque formation on HeLa cells by magnesium chloride. J. Gen. Virol. 9:251-253.
26. Chahal JS, Flint SJ. 2012. Timely synthesis of the adenovirus type 5 E1B 55-kilodalton protein is required for efficient genome replication in normal human cells. J. Virol. 86:3064 -3072.
27. Gonzalez R, Huang W, Finnen R, Bragg C, Flint SJ. 2006. Adenovirus E1B 55-kilodalton protein is required for both regulation ofmRNAexport and efficient entry into the late phase of infection in normal human fibroblasts. J. Virol. 80:964 -974.
28. Miller DL, Rickards B, Mashiba M, Huang W, Flint SJ. 2009. The adenoviral E1B 55-kilodalton protein controls expression of immune response genes but not p53-dependent transcription. J. Virol. 83:3591- 3603.